2005 Annual Meeting | Case Studies in Stroke

Date Wednesday 04/13/05

Time 07:00 PM - 10:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Case Studies Program

Director(s) Philip B. Gorelick, MD, MPH, F�鶹��ýӳ��

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should be able to better understand blood pressure management in acute and chronic stroke patients; understand the role of statins in first and recurrent stroke prevention; understand the role of the various antiplatelet agents in recurrent stroke prevention; be familiar with diagnostic studies used to decide whether intravenous or IA tPA should be given and the indications for these agents; be familiar with new data on the use of carotid endarterectomy in asymptomatic carotid stenosis patients; and be able to diagnose challenging stroke patients.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
07:00 PM - 07:20 PM		Case 1: Diagnostic Tests That Help You Decide Acute Ischemic Stroke Management in Mrs. Jones Louis R. Caplan, MD, F�鶹��ýӳ��
07:00 PM - 10:00 PM		Refreshments
07:20 PM - 07:40 PM		Case 2: Should I Be Administering IV or IA tPA? Louis R. Caplan, MD, F�鶹��ýӳ��
07:40 PM - 08:00 PM		Case 3: Six Key Questions About Blood Pressure Lowering In Acute or Chronic Stroke Management Philip B. Gorelick, MD, MPH, F�鶹��ýӳ��
08:00 PM - 08:10 PM		Break
08:10 PM - 08:30 PM		Case 4: Which Antiplatelet Agent and Why for Recurrent Stroke Prevention and Are Statin Agents Indicated? Philip B. Gorelick, MD, MPH, F�鶹��ýӳ��
08:30 PM - 08:50 PM		Case 5: Rule Out CNS Vasculitis: Overrated or Or the Real McCoy? Louis R. Caplan, MD, F�鶹��ýӳ��
08:50 PM - 09:00 PM		Break
09:00 PM - 09:20 PM		Case 6: White Matter Disease and Its Variations In Practice: What Does It All Mean and What Should We Be Doing About It? Philip B. Gorelick, MD, MPH, F�鶹��ýӳ��
09:20 PM - 09:40 PM		Case 7: Carotid Endarterectomy in Asymptomatic Carotid Stenosis: YES/NO
09:40 PM - 10:00 PM		Audience Presentation of Challenging Cases and Questions

Faculty Disclosures
Philip B. Gorelick, MD, MPH, F�鶹��ýӳ��	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Louis R. Caplan, MD, F�鶹��ýӳ��	No disclosure on file